Skip to content

The New Skin Stretching Device for Treatment of Limb Tension Wounds

The New Skin Stretching Device for Treatment of Limb Tension Wounds: A Multicenter Randomized Controlled Clinical Study

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03141502
Acronym
SSDRCT
Enrollment
100
Registered
2017-05-05
Start date
2017-05-11
Completion date
2018-10-31
Last updated
2017-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fractures, Open, Skin Expander, Trauma, Wounds and Injuries

Keywords

tension wound, skin stretching device, skin grafting

Brief summary

A randomized controlled trial is performed to evaluate the effectiveness and safety of the Skin Stretching Device (SSD) on limb tension incision closure by comparing whether the differences in wounds area, wounds closure time and scar assessment between the SSD and the skin grafting are statistically significant.

Detailed description

Design: This study is a multicenter and randomized control study with the participation of 15 major national or regional central hospitals. And the whole sample size is set to be 100 patients. Patients who have been screened by inclusion and exclusion criteria will be randomly (non-transparent envelope) assigned to Skin Stretching Group (SS Group) or Skin Grafting Group (SG Group). Patients of both group will undergo surgical debridement for the same principle, while the Skin Stretching Device is used for the patients of SS Group for incision closure and the Skin Grafting is used for the patients of SG group for incision closure. Outcome evaluation: Wound and scar evaluation during surgery, three and six months after surgery will include the following parameters: * surface area; * Vancouver scar scale (VSS) * vascularization and pigmentation; * dermal architecture. After 3 and 6 months patients will undergo a biopsy of the scar under local anesthesia. The experimental group, treated with the SSD will undergo one extra biopsy of the formerly stretched skin. Safety evaluation: During the trial, adverse events are observed and evaluated. Adverse reactions to clinical manifestations are followed and recorded till the symptoms disappear. The subject with serious adverse events shall withdraw from the study and be treated accordingly.

Interventions

DEVICESkin stretching device (SSD)

By making use of skin viscoelasticity, the special metal crochet of SSD would be embedded in both sides skin of the wound. Multiple cycles of stretching and relaxing wound lead to extended skin, changing the high tension incision into a low tension incision and facilitating the direct suture.

PROCEDURESkin grafting

the standard technique of skin grafting after wound preparation.

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age≥18 years old 2. Tension incision that cannot be directly closed due to limb trauma or surgical debridement 3. Incision that cannot be directly closed after the incision decompression for fascia compartment syndrome and ischemia and reperfusion injury 4. Both sides of the incision skin suitable for skin stretching

Exclusion criteria

1. Age \<18 years old 2. Skin disease 3. Keloid history 4. Local or systemic use of hormones 5. Systemic diseases: for example, diabetes, immunodeficiency disease, vascular disease and etc. 6. Other poor general state to result in inability for trial; 7. Mental illness.

Design outcomes

Primary

MeasureTime frameDescription
the change of surface area of the scarchange from surgery at 6 monthsit is performed by tracing the area of the scar directly onto non-stretchable transparent sterile sheets. then digitized and analyzed by software.

Secondary

MeasureTime frameDescription
Wound site and wound healing timefrom surgery to 6 monthsrecord the site of the operation, and the time from the beginning of surgery to the complete healing of the wound.
Vancouver scar scale (VSS)3 and 6 months after surgeryevaluate the scar scale by VSS
scar vascularization index3 and 6 months after surgeryuse photometric analyzer to measure its erythema index, assessing its angiogenesis and vascularization
Operation timeduring surgeryrefers to the time required for the application of skin stretching device or skin grafting
collagen fibers arrangement under electron microscopysurgery and 6 months after surgeryuse the drilling device to take the skin tissue of the diameter of 3mm for histological examination, measuring the collagen fibers arrangement by Electron microscopy
dermal matrix arrangement under electron microscopysurgery and 6 months after surgeryuse the drilling device to take the skin tissue of the diameter of 3mm for histological examination, measuring the dermal matrix arrangement by Electron microscopy
scar pigmentation index3 and 6 months after surgeryuse photometric analyzer to measure its melanin index, assessing its pigmentation

Countries

China

Contacts

Primary ContactJunwei Zong, MD
aweizone@163.com86041183635963
Backup ContactNuo Li
dyyykyb@163.com86041183635963

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026